NEW YORK (GenomeWeb News) – Fred Hutchinson Cancer Research Center yesterday announced that it is collaborating with South Korea-based NSB Postech on research into protein microarrays.
The partners are coordinating efforts to determine the efficacy of NSB’s NanoCones surface technology in creating proteomic microarrays to be used in studying human diseases, the Hutchinson Center said. The collaboration will include a comparison of slides created with NSB’s technology with current industry standard technology.
“We hope this will make our antibody arrays more sensitive and accurate,” Paul Lampe, a member of the Hutchinson Center’s Public Health Sciences Division and associate program head of molecular diagnostics, said in a statement.
NSB will fund the collaboration. Further terms of the alliance were not disclosed.